SEARCH

SEARCH BY CITATION

References

  • Aggarwal BB, Shishodia S. 2006. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397421.
  • Agriculture and Agri-Food Canada. 2009. What are functional foods and nutraceuticals. Available from http://www4.agr.gc.ca/AAFC-AAC/display-afficher.do?id=1171305207040&lang=eng . Accessed Mar 9, 2010.
  • Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A, Green J. 2009. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 101:296305.
  • Almeida L, Vaz-Da-Silva M, Falcao A, Soares E, Costa R, Loureiro AI, Fernandes-Lopes C, Rocha JF, Nunes T, Wright L, Soares-Da-Silva P. 2009. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res 53:S7S15.
  • Alvarez P, Alvarado C, Puerto M, Schlumberger A, Jimenez L, De La Fuente M. 2006. Improvement of leukocyte functions in prematurely aging mice after five weeks of diet supplementation with polyphenol-rich cereals. Nutrition 22:91321.
  • Anli RE, Vural N. 2009. Antioxidant phenolic substances of Turkish red wines from different wine regions. Molecules 14:28997.
  • Annadana S. 2008. Report package: global market reviews of functional food, new product development. Acessed from: http://just-food.com .
  • Antolovich M, Prenzler PD, Patsalides E, Mcdonald S, Robards K. 2002. Methods for testing antioxidant activity. Analyst 127:18398.
  • Appeldoorn MM, Venema DP, Peters THF, Koenen ME, Arts ICW, Vincken JP, Gruppen H, Keijer J, Hollman PCH. 2009a. Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro. J Agric Food Chem 57:76939.
  • Appeldoorn MM, Vincken JP, Gruppen H, Hollman PCH. 2009b. Procyanidin dimers A1, A2, and B2 are absorbed without conjugation or methylation from the small intestine of rats. J Nutr 139:146973.
  • Arnold RA, Noble AC. 1978. Bitterness and astringency of grape seed phenolics in a model wine solution. Am J Enol Viticult 29:1502.
  • Assuncao M, Santos-Marques MJ, Monteiro R, Azevedo I, Andrade JP, Carvalho F, Martins MJ. 2009. Red wine protects against ethanol-induced oxidative stress in rat liver. J Agric Food Chem 57:606673.
  • Auger C, Teissedre PL, Gerain P, Lequeux N, Bornet A, Serisier S, Besancon P, Caporiccio B, Cristol JP, Rouanet JM. 2005. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J Agric Food Chem 53:201521.
  • Australian Wine and Brandy Corporation. 2010. Guide to wine law: health claims. Available from: http://www.wineaustralia.com/australia/Default.aspx?tabid=405 . Accessed Mar 7, 2010.
  • Auw JM, Blanco V, Okeefe SF, Sims CA. 1996. Effect of processing on the phenolics and color of Cabernet Sauvignon, Chambourcin, and noble wines and juices. Am J Enol Viticult 47:27986.
  • Baba S, Osakabe N, Natsume M, Muto Y, Takizawa T, Terao J. 2001. In vivo comparison of the bioavailability of (+)-catechin, (−)-epicatechin and their mixture in orally administered rats. J Nutr 131:288591.
  • Barreiro-Hurle J, Colombo S, Cantos-Villar E. 2008. Is there a market for functional wines? consumer preferences and willingness to pay for resveratrol-enriched red wine. Food Qual Prefer 19:36071.
  • Bastianetto S, Dumont Y, Han Y, Quirion R. 2009. Comparative neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site CNS Neurosci Therapeut 15:7683.
  • Bastianetto S, Quirion R. 2002. Natural extracts as possible protective agents of brain aging. Neurobiol Aging 23:8917.
  • Basu SK, Thomas JE, Acharya SN. 2007. Prospects for growth in global nutraceutical and functional food markets: a Canadian perspective. Aust J Basic Appl Sci 1:63749.
  • Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang MY, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, De Cabo R, Sinclair DA. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:33742.
  • Baur JA, Sinclair DA. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493506.
  • Benedetti A, Parent ME, Siemiatycki J. 2009. Lifetime consumption of alcoholic beverages and risk of 13 types of cancer in men: results from a case-control study in Montreal. Cancer Detect Prevent 32:35262.
  • Bentivegna SS, Whitney KM. 2002. Subchronic 3-month oral toxicity study of grape seed and grape skin extracts. Food Chem Toxicol 40:173143.
  • Berli F, D’angelo J, Cavagnaro B, Bottini R, Wuilloud R, Silva MF. 2008. Phenolic composition in grape(Vitis vinifera L. cv. Malbec) ripened with different solar UV-B radiation levels by capillary zone electrophoresis. J Agric Food Chem 56:28928.
  • Bertelli AAE, Migliori M, Filippi C, Gagliano N, Donetti E, Panichi V, Scalori V, Colombo R, Mannari C, Tillement JP, Giovannini L. 2005. Effect of ethanol and red wine on ochratoxin a-induced experimental acute nephrotoxicity. J Agric Food Chem 53:69249.
  • Bongaerts BWC, Van Den Brandt PA, Goldbohm RA, De Goeij AFPM, Weijenberg MP. 2008. Alcohol consumption, type of alcoholic beverage and risk of colorectal cancer at specific subsites. Int J Cancer 123:24117.
  • Boots AW, Haenen GRMM, Bast A. 2008. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:32537.
  • Bosetti C, La Vecchia C, Negri E, Franceschi S. 2000. Wine and other types of alcoholic beverages and the risk of esophageal cancer. Eur J Clin Nutr 54:91820.
  • Brand-Miller JC, Fatima K, Middlemiss C, Bare M, Liu V, Atkinson F, Petocz P. 2007. Effect of alcoholic beverages on postprandial glycemia and insulinemia in lean, young, healthy adults. Am J Clin Nutr 85:154551.
  • Brossaud F, Cheynier V, Noble AC. 2001. Bitterness and astringency of grape and wine polyphenols. Aust J Grape Wine Res 7:339.
  • Cancer Council Australia. 2010. Alcohol. Available from: http://www.cancer.org.au//cancersmartlifestyle/nutritionphysicalactivity/alcohol.htm . Accessed Mar 6, 2010.
  • Caridi A, Cufari A, Lovino R, Palumbo R, Tedesco I. 2004. Influence of yeast on polyphenol composition of wine. Food Technol Biotechnol 42:3740.
  • Casalini C, Lodovici M, Briani C, Paganelli G, Remy S, Cheynier V, Dolara P. 1999. Effect of complex polyphenols and tannins from red wine (WCPT) on chemically induced oxidative DNA damage in the rat. Eur J Nutr 38:1905.
  • Castellari M, Spinabelli U, Riponi C, Amati A. 1998. Influence of some technological practices on the quantity of resveratrol in wine. Zeitschrift Fur Lebensmittel-Untersuchung Und-Forschung a-Food Res Technol 206:1515.
  • Castillo-Pichardo L, Martinez-Montemayor MM, Martinez JE, Wall KM, Cubano LA, Dharmawardhane S. 2009. Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin Exp Metastasis 26:50516.
  • Castillo-Sanchez JX, Garcia-Falcon MS, Garrido J, Martinez-Carballo E, Martins-Dias LR, Mejuto XC. 2008. Phenolic compounds and colour stability of Vinhao wines: influence of wine-making protocol and fining agents. Food Chem 106:1826.
  • Choi H, Curhan G. 2004. Beer, liquor, and wine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum 50:S480.
  • Choi EM, Hwang JK. 2003. Effects of (+)-catechin on the function of osteoblastic cells. Biol Pharm Bull 26:5236.
  • Clare SS, Skurray G, Shalliker RA. 2004. Effect of pomace-contacting method on the concentration of cis- and trans-resveratrol and resveratrol glucoside isomers in wine. Am J Enol Viticult 55:4016.
  • Clare SS, Skurray GR, Shalliker RA. 2005. Effect of yeast strain selection on the concentration of cis- and trans-resveratrol and resveratrol glucoside isomers in wine. Aust J Grape Wine Res 11:914.
  • Clarkson PM, Thompson HS. 2000. Antioxidants: what role do they play in physical activity and health Am J Clin Nutr 72:637S-46S.
  • Collie A, Morley G. 2007. Do polyphenols affect human cognitive function Curr Top Nutraceut Res 5:1458.
  • Cooper KA, Chopra M, Thurnham DI. 2004. Wine polyphenols and promotion of cardiac health. Nutr Res Rev 17:11129.
  • Cordova AC, Jackson LM, Berke-Schlessel DW, Sumpio BE. 2005. The cardiovascular protective effect of red wine. J Am Coll Surgeons 200:42839.
  • Criqui MH, Ringel BL. 1994. Does diet or alcohol explain the French paradox. Lancet 344:171923.
  • Croom K, Lewis D, Marchell T, Lesser ML, Reyna VF, Kubicki-Bedford L, Feffer M, Staiano-Coico L. 2009. Impact of an online alcohol education course on behavior and harm for incoming first-year college students: short-term evaluation of a randomized trial. J Am Coll Health 57:44554.
  • Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. 2004. Resveratrol-associated renal toxicity. Toxicol Sci 82:6149.
  • Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, Hu FR, Ballabh P, Podlutsky A, Losonczy G, De Cabo R, Mathew R, Wolin MS, Ungvari Z. 2009. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 54:66875.
  • Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, Ungvari Z. 2006. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-KB inhibition. Am J Physiol-Heart Circ Physiol 291:H16949.
  • Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT, Cai L, Cozen W, Mack TM, Lu QY, Zhang ZF. 2008. Dietary flavonoid intake and lung cancer: a population-based case-control study. Cancer 112:22418.
  • Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K. 2009. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 101:38498.
  • Das S, Alagappan VKT, Bagchi D, Sharma HS, Maulik N, Das DK. 2005. Coordinated induction of inos-vegf-kdr-enos after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vasc Pharm 42:2819.
  • Das DK, Maulik N. 2006. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Intervent 6:3647.
  • Davalos A, Castilla P, Gomez-Cordoves C, Bartolome B. 2006. Quercetin is bioavailable from a single ingestion of grape juice. Int J Food Sci Nutr 57:3918.
  • Davalos A, De La Pena G, Sanchez-Martin CC, Guerra MT, Bartolome B, Lasuncion MA. 2009. Effects of red grape juice polyphenols in NADPH oxidase subunit expression in human neutrophils and mononuclear blood cells. Br J Nutr 102:112535.
  • De Andres-De Prado R, Yuste-Rojas M, Sort X, Andres-Lacueva C, Torres M, Lamuela-Raventos RM. 2007. Effect of soil type on wines produced from Vitis vinifera L. cv. Grenache in commercial vineyards. J Agric Food Chem 55:77986.
  • De Lorgeril M, Salen P, Martin JL, Boucher F, De Leiris J. 2008. Interactions of wine drinking with omega-3 fatty acids in patients with coronary heart disease: a fish-like effect of moderate wine drinking. Am Heart J 155:17581.
  • De Quiros ARB, Lage-Yusty MA, Lopez-Hernandez J. 2009. HPLC-analysis of polyphenolic compounds in Spanish white wines and determination of their antioxidant activity by radical scavenging assay. Food Res Int. 42:101822.
  • De Vries JHM, Hollman PCH, Van Amersfoort I, Olthof MR, Katan MB. 2001. Red wine is a poor source of bioavailable flavonols in men. J Nutr 131:7458.
  • Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, De Gaetano G. 2006. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 166:243745.
  • Diplock AT, Aggett PJ, Ashwell M, Bornet F, Fern EB, Roberfroid MB. 1999. Scientific concepts of functional foods in Europe consensus document. Br J Nutr 81:S1S27.
  • Do GM, Kwon EY, Kim HJ, Jeon SM, Ha TY, Park T, Choi MS. 2008. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo e-deficient mice. Biochem Biophys Res Commun 374:559.
  • Dolara P, Luceri C, De Filippo C, Femia AP, Giovannelli L, Caderni G, Cecchini C, Silvi S, Orpianesi C, Cresci A. 2005. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in f344 rats. Mutat Res-Fundam Mol Mech Mutagen 591:23746.
  • Donovan JL, Bell JR, Kasim-Karakas S, German JB, Walzem RL, Hansen RJ, Waterhouse AL. 1999. Catechin is present as metabolites in human plasma after consumption of red wine. J Nutr 129:16628.
  • Dornin R. 2000. Fighting words over wine labels aired in San Francisco. Available from: http://archives.cnn.com/2000/HEALTH/05/23/wine.label/ . Accessed Mar 7, 2010.
  • Dragoni S, Gee J, Bennett R, Valoti M, Sgaragli G. 2006. Red wine alcohol promotes quercetin absorption and directs its metabolism towards isorhamnetin and tamarixetin in rat intestine in vitro. Br J Pharmacol 147:76571.
  • Drewnowski A, Gomez-Carneros C. 2000. Bitter taste, phytonutrients, and the consumer: a review. Am J Clin Nutr 72:142435.
  • Droulez V. 2005. The future of functional foods. Available from: http://www.ferret.com.au/n/The-future-of-functional-foods-n680237 . Accessed Dec 12, 2009.
  • Dunnick JK, Hailey JR. 1992. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam Appl Toxicol 19:42331.
  • Ebeler SE, Brenneman CA, Kim GS, Jewell WT, Webb MR, Chacon-Rodriguez L, Macdonald EA, Cramer AC, Levi A, Ebeler JD, Islas-Trejo A, Kraus A, Hinrichs SH, Clifford AJ. 2002. Dietary catechin delays tumor onset in a transgenic mouse model. Am J Clin Nutr 76:86572.
  • Ebeler SE, Dingley KH, Ubick E, Abel S, Mitchell AE, Burns SA, Steinberg FM, Clifford AJ. 2005. Animal models and analytical approaches for understanding the relationships between wine and cancer. Drugs Under Exp Clin Res 31:1927.
  • Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ. 2008. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138:161521.
  • Ellison RC, Zhang YQ, Qureshi MM, Knox S, Arnett DK, Province MA. 2004. Lifestyle determinants of high-density lipoprotein cholesterol: the national heart, lung, and blood institute family heart study. Am Heart J 147:52935.
  • Erdman JW Jr, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, Messina M, Scalbert A, Vita J, Williamson G, Burrowes J. 2007. Flavonoids and heart health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 137:718S37S.
  • Feliciano RP, Bravo MN, Pires MM, Serra AT, Duarte CM, Boas LV, Bronze MR. 2009. Phenolic content and antioxidant activity of Moscatel dessert wines from the seta(o)bal region in Portugal. Food Anal Methods 2:14961.
  • Ferguson LR. 2001. Role of plant polyphenols in genomic stability. Mutat Res-Fundam Mol Mech Mutagenesis 475:89111.
  • Frank J, Lundh T, Parker RS, Swanson JE, Vessby B, Kamal-Eldin A. 2003. Dietary (+)-catechin and BHT markedly increase alpha-tocopherol concentrations in rats by a tocopherol-omega-hydroxylase-independent mechanism. J Nutr 133:31959.
  • Frankel EN, Meyer AS. 2000. The problems of using one-dimensional methods to evaluate multifunctional food and biological antioxidants. J Sci Food Agric 80:192541.
  • Fresco P, Borges F, Diniz C, Marques MPM. 2006. New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26:74766.
  • Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, Hunter DJ, Hankinson SE, Hennekens CH, Rosner B, Speizer FE, Willett WC. 1995. Alcohol-consumption and mortality among women. N Engl J Med 332:124550.
  • Fuhrman B, Aviram M. 2001. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidology 12:418.
  • Fujii H, Nishioka H, Wakame K, Magnuson BA, Roberts A. 2008. Acute, subchronic and genotoxicity studies conducted with oligonol, an oligomerized polyphenol formulated from lychee and green tea extracts. Food Chem Toxicol 46:355362.
  • Fujimoto A, Sakanashi Y, Matsui H, Oyama T, Nishimura Y, Masuda T, Oyama Y. 2009. Cytometric analysis of cytotoxicity of polyphenols and related phenolics to rat thymocytes: potent cytotoxicity of resveratrol to normal cells. Basic Clin Pharmacol Toxicol 104: 45562.
  • Garcia-Alonso M, Minihane AM, Rimbach G, Rivas-Gonzalo JC, De Pascual-Teresa S. 2009. Red wine anthocyanins are rapidly absorbed in humans and affect monocyte chemoattractant protein 1 levels and antioxidant capacity of plasma. J Nutr Biochem 20:5219.
  • Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, Van Den Brandt PA, English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Hankinson SE, Horn-Ross PL, Leitzmann M, Mannisto S, Marshall JR, Mccullough ML, Miller AB, Reding DJ, Robien K, Rohan TE, Schatzkin A, Stevens VL, Stolzenberg-Solomon RZ, Verhage BAJ, Wolk A, Ziegler RG, Smith-Warner SA. 2009. Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev 18:76576.
  • Goldberg DM, Dam J, Carey M, Soleas GJ. 2000. Cultivar-specific patterns of polyphenolic constituents in wines from the Finger Lakes region of New York State. J Wine Res 11:15564.
  • Goldberg DM, Karumanchiri A, Tsang E, Soleas GJ. 1998b. Catechin and epicatechin concentrations of red wines: regional and cultivar-related differences. Am J Enology Viticulture 49:2334.
  • Goldberg DM, Ng E, Karumanchiri A, Diamandis EP, Soleas GJ. 1996a. Resveratrol glucosides are important components of commercial wines. Am J Enol Viticult 47:41520.
  • Goldberg DM, Tsang E, Karumanchiri A, Diamandis EP, Soleas G, Ng E. 1996b. Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal Chem 68:168894.
  • Goldberg DM, Tsang E, Karumanchiri A, Soleas GJ. 1998a. Quercetin and p-coumaric acid concentrations in commercial wines. Am J Enol Viticult 49:14251.
  • Gomez-Plaza E, Gil-Munoz R, Lopez-Roca JM, Martinez-Cutillas A, Fernandez-Fernandez JI. 2001. Phenolic compounds and color stability of red wines: effect of skin maceration time. Am J Enol Viticult 52:26670.
  • Goncalves FJ, Jordao AM. 2009. Changes in antioxidant activity and the proanthocyanidin fraction of red wine aged in contact with Portuguese (Quercus pyrenaica willd.) and American (Quercus alba L.) oak wood chips. Ital J Food Sci 21:5164.
  • Gonzalez-Barrio R, Beltran D, Cantos E, Gil MI, Espin JC, Tomas-Barberan FA. 2006. Comparison of ozone and UV-C treatments on the postharvest stilbenoid monomer, dimer, and trimer induction in var. ‘Superior’ white table grapes. J Agric Food Chem 54:42228.
  • Gorelik S, Ligumsky M, Kohen R, Kanner J. 2008. A novel function of red wine polyphenols in humans: prevention of absorption of cytotoxic lipid peroxidation products. FASEB J 22:416.
  • Gorny D. 2007. Advertising for wine after Regulation (EC) 1924/2006—health claims regulation, or how to communicate health benefits of wine to the consumer. Rivista Di Diritto Alimentare 3:335.
  • Gougeon RD, Lucio M, Frommberger M, Peyron D, Chassagne D, Alexandre H, Feuillat F, Voilley A, Cayot P, Gebefugi I, Hertkorn N, Schmitt-Kopplin P. 2009. The chemodiversity of wines can reveal a metabologeography expression of cooperage oak wood. Proc Natl Acad Sci USA 106:91749.
  • Gougoulias N. 2009. Comparative study on the polyphenol composition and antioxidant potential of Peloponnese wines. Oxidation Commun 32:47382.
  • Gronbaek M. 2009. The positive and negative health effects of alcohol- and the public health implications. J Int Med 265:40720.
  • Guarda E, Godoy I, Foncea R, Perez DD, Romero C, Venegas R, Leighton F. 2005. Red wine reduces oxidative stress in patients with acute coronary syndrome. Int J Cardiol 104:358.
  • Guerrero RF, Garcia-Parrilla MC, Puertas B, Cantos-Villar E. 2009. Wine, resveratrol and health: a review. Nat Prod Commun 4:63558.
  • Hakimuddin F, Tiwari K, Paliyath G, Meckling K. 2008. Grape and wine polyphenols down-regulate the expression of signal transduction genes and inhibit the growth of estrogen receptor-negative mda-mb231 tumors in nu/nu mouse xenografts. Nutr Res 28:70213.
  • Halliwell B. 1987. Oxidants and human-disease: some new concepts. FASEB J 1:35864.
  • Hamid A, Wani NA, Kaur J. 2009. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption – association with epigenome stability and cancer development. FEBS J 276:217591.
  • Harper CE, Patel BB, Wang J, Arabshahi A, Eltoum IA, Lamartiniere CA. 2007. Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 28:194653.
  • Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. 2007. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcino genic properties. Food Chem Toxicol 45:2179205.
  • Hasler CM. 1998. Functional foods: their role in disease prevention and health promotion. Food Technol 52(11):6370.
  • Hattori R, Otani H, Maulik N, Das DK. 2002. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol-Heart Circ Physiol 282:H198895.
  • He S, Sun CR, Pan YJ. 2008. Red wine polyphenols for cancer prevention. Int J Mol Sci 9:84253.
  • Hertog MGL, Feskens EJM, Kromhout D. 1997. Antioxidant flavonols and coronary heart disease risk. Lancet 349:699.
  • Hogan S, Zhang L, Li JR, Zoecklein B, Zhou KQ. 2009. Antioxidant properties and bioactive components of Norton (Vitis aestivalis) and Cabernet Franc (Vitis vinifera) wine grapes. LWT Food Sci Technol 42:126974.
  • Hope C, Planutis K, Planutiene M, Moyer MP, Johal KS, Woo J, Santoso C, Hanson JA, Holcombe RF. 2008. Low concentrations of resveratrol inhibit wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol Nutr Food Res 52: S5261.
  • Huang SM, Wu CH, Yen GC. 2006. Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for ages. Mol Nutr Food Res 50:112939.
  • Ihm SH, Lee JO, Kim SJ, Seung KB, Schini-Kerth VB, Chang K, Oak MH. 2009. Catechin prevents endothelial dysfunction in the prediabetic stage of oletf rats by reducing vascular NADPH oxidase activity and expression. Atherosclerosis 206:4753.
  • Intl. Centre for Alcohol Policy. 2010. International drinking guidelines. Available from: http://www.icap.org/PolicyTools/ICAPPolicyGuides/ . Accessed Mar 7, 2010.
  • Jackson DI, Lombard PB. 1993. Environmental and management-practices affecting grape composition and wine quality: a review. Am J Enol Viticult 44:40930.
  • Jagtap S, Meganathan K, Wagh V, Winkler J, Hescheler J, Sachinidis A. 2009. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem 16:145162.
  • Jimenez JB, Orea JM, Urena AG, Escribano P, De La Osa PL, Guadarrama A. 2007. Short anoxic treatments to enhance trans-resveratrol content in grapes and wine. Eur Food Res Technol 224:3738.
  • Jo JY, Lee CY. 2007. Cancer chemoprevention by dietary proanthocyanidins. Food Sci Biotechnol 16:5018.
  • Joseph A, Ackerman D, Talley J, Johnstone J, Kupersmith J. 1993. Manifestations of coronary atherosclerosis in young trauma victims: an autopsy study. J Am Coll Cardiol 22:45967.
  • Juan ME, Vinardell MP, Planas JM. 2002. The daily oral administration, of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 132:25760.
  • Jung SK, Lee KW, Byun S, Kang NJ, Lim SH, Heo YS, Bode AM, Bowden GT, Lee HJ, Dong ZG. 2008. Myricetin suppresses UVB-induced skin cancer by targeting fyn. Cancer Res 68:60219.
  • Kahraman A, Inal ME. 2002. Protective effects of quercetin on ultraviolet a light-induced oxidative stress in the blood of rat. J Appl Toxicol 22:3039.
  • Kallberg H, Jacobsen S, Bengtsson C, Pedersen M, Padyukov L, Garred P, Frisch M, Karlson EW, Klareskog L, Alfredsson L. 2009. Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies. Ann Rheum Dis 68:2227.
  • Kamper-Jorgensen M, Gronbaek M, Tolstrup J, Becker U. 2004. Alcohol and cirrhosis: dose-response or threshold effect J Hepatol 41:2530.
  • Karatzi K, Papamichael C, Karatzis E, Papaioannou TG, Voidonikola PT, Vamvakou GD, Lekakis J, Zampelas A. 2008. Postprandial improvement of endothelial function by red wine and olive oil antioxidants: a synergistic effect of components of the Mediterranean diet. J Am Coll Nutr 27:44853.
  • Kasdallah-Grissa A, Mornagui B, Aouani E, Hammami M, El May M, Gharbi N, Kamoun A, El-Fazaa S. 2007. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci 80:10339.
  • Khan N, Mukhtar H. 2008. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 269:26980.
  • King DE, Mainous AG, Geesey ME. 2008. Adopting moderate alcohol consumption in middle age: subsequent cardiovascular events. Am J Med 121:2016.
  • Klatsky AL. 2004. Alcohol and cardiovascular health. Integr Comp Biol 44:3248.
  • Kloner RA, Rezkalla SH. 2007. To drink or not to drink? That is the question. Circulation 116:130617.
  • Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. 2002. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:5608.
  • Kotilainen L, Rajalahti R, Ragasa C, Pehu E. 2006. Health enhancing foods: opportunities for strengthening the sector in developing countries. The World Bank: Washington D.C.
  • Koundouras S, Marinos V, Gkoulioti A, Kotseridis Y, Van Leeuwen C. 2006. Influence of vineyard location and vine water status on fruit maturation of nonirrigated cv. Agiorgitiko (Vitis vinifera L.). Effects on wine phenolic and aroma components. J Agric Food Chem 54:507786.
  • Kraft TE, Parisotto D, Schempp C, Efferth T. 2009. Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr 49:78299.
  • Kraus B, Wolff H, Heilmann J, Elstner EF. 2007. Influence of Hypericum perforatum extract and its single compounds on amyloid-beta mediated toxicity in microglial cells. Life Sci 81:88494.
  • Krystallis A, Maglaras G, Mamalis S. 2008. Motivations and cognitive structures of consumers in their purchasing of functional foods. Food Qual Preference 19:52538.
  • Kweon S, Kim Y, Choi H. 2003. Grape extracts suppress the formation of preneoplastic foci and activity of fatty acid synthase in rat liver. Exp Mol Med 35:3718.
  • Lachenmeier DW, Kanteres F, Rehm J. 2009. Carcinogenicity of acetaldehyde in alcoholic beverages: risk assessment outside ethanol metabolism. Addiction 104:53350.
  • Lagrue-Lak-Hal AH, Andriantsitohaina R. 2006. Red wine and cardiovascular risks. Arch Des Mal Du Coeur Et Des Vaisseaux 99:12305.
  • Lanas A, Serrano P, Bajador E, Fuentes J, Guardia J, Sainz R. 2000. Effect of red wine and low dose aspirin on the risk of upper gastrointestinal bleeding: a case-control study. Gastroenterology 118:A251.
  • Lang IA, Melzer D. 2009. Moderate alcohol consumption in later life: time for a trial J Am Geriatr Soc 57:11102.
  • La Vecchia C, Zhang ZF, Altieri A. 2008. Alcohol and laryngeal cancer: an update. Eur J Cancer Prev 17:11624.
  • Lee SJ, Chung IM, Kim MY, Park KD, Park WH, Moon HI. 2009a. Inhibition of lung metastasis in mice by oligonol. Phytother Res 23:10436.
  • Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, Hwang MK, Bowden GT, Bode AM, Lee HJ, Dong Z. 2008. Raf and mek protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 68:94655.
  • Lee KW, Lee HJ. 2006. The roles of polyphenols in cancer chemoprevention. Biofactors 26:10521.
  • Lee EO, Lee HJ, Hwang HS, Ahn KS, Chae C, Kang KS, Lu JX, Kim SH. 2006. Potent inhibition of Lewis lung cancer growth by heyneanol a from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis 27:205969.
  • Lee SJ, Sudore RL, Williams BA, Lindquist K, Chen HL, Covinsky KE. 2009b. Functional limitations, socioeconomic status, and all-cause mortality in moderate alcohol drinkers. J Am Geriatr Soc 57:95562.
  • Lefevre J, Michaud SE, Haddad P, Dussault S, Menard C, Groleau J, Turgeon J, Rivard A. 2007. Moderate consumption of red wine (Cabernet Sauvignon) improves ischemia-induced neovascularization in apoe-deficient mice: effect on endothelial progenitor cells and nitric oxide. FASEB J 21:384552.
  • Lesschaeve I, Noble AC. 2005. Polyphenols: factors influencing their sensory properties and their effects on food and beverage preferences. Am J Clin Nutr 81:330S5S.
  • Lesser S, Wolffram S. 2006. Oral bioavailability of the flavonol quercetin: a review. Curr Top Nutraceutical Res 4:23956.
  • Lethbridge A, Patch C, Ridges L. 2006. The Australian functional foods landscape. National Centre of Excellence in Functional Foods: Wollongong.
  • Levitt T. 2004. Marketing myopia. Harvard Bus Rev 82:13849.
  • Lewis S, Campbell S, Proudfoot E, Weston A, Cotter T, Bishop J. 2008. Alcohol as a cause of Cancer. Sydney : Cancer Insti. NSW. Accessed Feb 2, 2010.
  • Li H, Wang XY, Li Y, Li PH, Wang H. 2009. Polyphenolic compounds and antioxidant properties of selected China wines. Food Chem 112:45460.
  • Li LT, Yin LJ, Saito M. 2004. Function of traditional foods and food culture in China. Japan Agric Res Q 38:21320.
  • Logan BA, Hammond MP, Stormo BM. 2008. The French paradox: determining the superoxide-scavenging capacity of red wine and other beverages. Biochem Mol Biol Educ 36:3942.
  • Maletie E, Kontic JK, Preiner D, Jeromel A, Patz CD, Dietrich H. 2009. Anthocyanin profile and antioxidative capacity of some autochthonous Croatian red wines. J Food Agric Environ 7:4851.
  • Manach C, Williamson G, Morand C, Scalbert A, Remesy C. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S42S.
  • Mandel S, Youdim MBH. 2004. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37:30417.
  • Marques-Vidal P, Cambou JP, Nicaud V, Luc G, Evans A, Arveiler D, Bingham A, Cambien F. 1995. Cardiovascular risk-factors and alcohol-consumption in France and Northern-Ireland. Atherosclerosis 115:22532.
  • Mattisson I, Wirfalt E, Wallstrom P, Gullberg B, Olsson H, Berglund G. 2004. High fat and alcohol intakes are risk factors of postmenopausal breast cancer: a prospective study from the malmo diet and cancer cohort. Int J Cancer 110:58997.
  • McDonald S, Prenzler PD, Antolovich M, Robards K. 2001. Phenolic content and antioxidant activity of olive extracts. Food Chem 73:7384.
  • McGill HC, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, Malcom GT, Tracy RE, Oalmann MC, Strong JP. 2000. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. Arterioscler Thromb Vasc Biol 20:19982004.
  • McKillop IH, Schrum LW. 2009. Role of alcohol in liver carcinogenesis. Semin Liver Dis 29:22232.
  • Meinhold CL, Park Y, Stolzenberg-Solomon RZ, Hollenbeck AR, Schatzkin A, De Gonzalez AB. 2009. Alcohol intake and risk of thyroid cancer in the NIH-AARP diet and health study. Br J Cancer 101:16304.
  • Middleton E, Kandaswami C, Theoharides TC. 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673751.
  • Milner JA. 1999. Functional foods and health promotion. J Nutr 129:1395S7S.
  • Mizutani K, Ikeda K, Kawai Y, Yamori Y. 2001. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 28(1-2):559.
  • Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, Hara Y, Ikeda M, Tomita T. 2001. Tea catechins prevent the development of atherosclerosis in apoprotein e-deficient mice. J Nutr 131:2732.
  • Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC, Madamanchi NR, Kim CH. 2003. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of erk1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 301:106978.
  • Mukamal KJ, Rimm EB. 2008. Alcohol consumption: risks and benefits. Curr Atheroscler Rep 10:53643.
  • Murakami A, Ashida H, Terao J. 2008. Multitargeted cancer prevention by quercetin. Cancer Lett 269:31525.
  • Nardini M, Natella F, Scaccini C. 2007. Role of dietary polyphenols in platelet aggregation: a review of the supplementation studies. Platelets 18:22443.
  • Natella F, Nardini M, Virgili F, Scaccini C. 2006. Role of dietary polyphenols in the platelet aggregation network: a review of the in vitro studies. Curr Top Nutraceutical Res 4:121.
  • Natl. Heart Foundation. 2009. Healthy Eating and Drinking. Available from: http://www.heartfoundation.org.au/sites/HealthyEating/SiteCollectionDocuments/Dietary%20fats%20healthy%20eating%20messages.pdf . Accessed Mar 6, 2010.
  • Nigdikar SV, Williams NR, Griffin BA, Howard AN. 1998. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 68:25865.
  • Nikfardjam MSP, Mark L, Avar P, Figler M, Ohmacht R. 2006. Polyphenols, anthocyanins, and trans-resveratrol in red wines from the Hungarian Villany region. Food Chem 98:45362.
  • Noe V, Penuelas S, Lamuela-Raventos RM, Permanyer J, Ciudad CJ, Izquierdo-Pulido M. 2004. Epicatechin and a cocoa polyphenolic extract modulate gene expression in human caco-2 cells. J Nutr 134:250916.
  • Noll C, Hamelet J, Matulewicz E, Paul JL, Delabar JM, Janel N. 2009. Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice. J Nutr Biochem 20:58696.
  • Norata GD, Marchesi P, Passamonti S, Pirillo A, Violi F, Catapano AL. 2007. Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein e deficient mice. Atherosclerosis 191:26571.
  • Norrie P. 2005. Wine and health through the ages with special reference to Australia The University of Western Sydney. Available from: http://www.drnorrie.info/downloads/drnorriethesis/DrNorrieThesis.pdf . Accessed Dec 21, 2009.
  • Norris F, Hesser A. 2003. U.S. to allow wine labels that list health claims. Available from: http://www.nytimes.com/2003/03/01/business/us-to-allow-wine-labels-that-list-health-claims.html?pagewanted=1 . Accessed Mar 7, 2010.
  • Nothlings U, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. 2007. Flavonols and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol 166:92431.
  • Okamoto T. 2005. Safety of quercetin for clinical application (review). Int J Mol Med 16:2758.
  • Ossola B, Kaariainen TM, Mannisto PT. 2009. The multiple faces of quercetin in neuroprotection. Expert Opin Drug Saf 8:397409.
  • Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. 1995. The red wine phenolics trans-resveratrol and quercetin block human platelet-aggregation and eicosanoid synthesis: implications for protection against coronary heart-disease. Clin Chim Acta 235:20719.
  • Pandeya N, Williams G, Green AC, Webb PM, Whiteman DC. 2009. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology 136:121524.
  • Peleg H, Gacon K, Schlich P, Noble AC. 1999. Bitterness and astringency of flavan-3-ol monomers, dimers and trimers. J Sci Food Agric 79:11238.
  • Perez-Jimenez J, Saura-Calixto F. 2008. Grape products and cardiovascular disease risk factors. Nutr Res Rev 21:15873.
  • Petti S. 2009. Lifestyle risk factors for oral cancer. Oral Oncol 45:34050.
  • Piantelli M, Rossi C, Iezzi M, La Sorda R, Iacobelli S, Alberti S, Natali PG. 2006. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. J Cell Physiol 207:239.
  • Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, Ruparelia KC, Lamb JH, Farmer PB, Stanley LA, Burke MD. 2002. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome p450 enzyme cypibi. Br J Cancer 86:7748.
  • Prajitna A, Dami IE, Steiner TE, Ferree DC, Scheerens JC, Schwartz SJ. 2007. Influence of cluster thinning on phenolic composition, resveratrol, and antioxidant capacity in Chambourcin wine. Am J Enol Viticult 58:34650.
  • Prescott J, Norris L, Kunst M, Kim S. 2005. Estimating a “consumer rejection threshold” for cork taint in white wine. Food Qual Prefer 16:3459.
  • Price SF, Breen PJ, Valladao M, Watson BT. 1995. Cluster sun exposure and quercetin in Pinot-Noir grapes and wine. Am J Enol Viticult 46:18794.
  • Provencher V, Polivy J, Herman CP. 2009. Perceived healthiness of food. If it's healthy, you can eat more! Appetite 52:3404.
  • Radovanovic A, Radovanovic B, Jovancicevic B. 2009. Free radical scavenging and antibacterial activities of southern Serbian red wines. Food Chem 117:32631.
  • Ramadori G, Gautron L, Fujikawa T, Vianna CR, Elmquist JK, Coppari R. 2009. Central administration of resveratrol improves diet-induced diabetes. Endocrinology 150:532633.
  • Rangan GK, Wang YP, Harris DCH. 2002. Dietary quercetin augments activator protein-1 and does not reduce nuclear factor-kappa b in the renal cortex of rats with established chronic glomerular disease. Nephron 90:3139.
  • Rasmussen SE, Frederiksen H, Krogholm KS, Poulsen L. 2005. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res 49:15974.
  • Renaud S, De Lorgeril M. 1992. Wine, alcohol, platelets, and the French paradox for coronary heart-disease. Lancet 339:15236.
  • Rietjens IMCM, Alink GM. 2006. Future of toxicology – low-dose toxicology and risk–benefit analysis. Chem Res Toxicol 19:97781.
  • Rifici VA, Schneider SH, Khachadurian AK. 2002. Lipoprotein oxidation mediated by j774 murine macrophages is inhibited by individual red wine polyphenols but not by ethanol. J Nutr 132:25327.
  • Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. 1999. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br Med J 319:15238D.
  • Rohrmann S, Linseisen J, Vrieling A, Boffetta P, Stolzenberg-Solomon RZ, Lowenfels AB, Jensen MK, Overvad K, Olsen A, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Misirli G, Lagiou P, Trichopoulou A, Kaaks R, Bergmann MM, Boeing H, Bingham S, Khaw KT, Allen N, Roddam A, Palli D, Pala V, Panico S, Tumino R, Vineis P, Peeters PHM, Hjartaker A, Lund E, Cornejo MLR, Agudo A, Arriola L, Sanchez MJ, Tormo MJ, Gurrea AB, Lindkvist B, Manjer J, Johansson I, Ye WM, Slimani N, Duell EJ, Jenab M, Michaud DS, Mouw T, Riboli E, Bueno-De-Mesquita HB. 2009. Ethanol intake and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition (epic). Cancer Causes Control 20:78594.
  • Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Bohm M. 2002. Inhibition of the pdgf receptor by red wine flavonoids provides a molecular explanation for the “French paradox. FASEB J 16:195860.
  • Rossi M, Negri E, Talamini R, Bosetti C, Parpinel M, Gnagnarella P, Franceschi S, Dal Maso L, Montella M, Giacosa A, La Vecchia C. 2006. Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prevention 15:15558.
  • Roura E, Andres-Lacueva C, Estruch R, Mata-Bilbao ML, Izquierdo-Pulido M, Waterhouse AL, Lamuela-Raventos RM. 2007. Milk does not affect the bioavailability of cocoa powder flavonoid in healthy human. Ann Nutr Metab 51:4938.
  • Ruan HL, Yang Y, Zhu XN, Wang XL, Chen R. 2009. Neuroprotective effects of (+/−)-catechin against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (mptp)-induced dopaminergic neurotoxicity in mice. Neurosci Lett 450:1527.
  • Ruano-Ravina A, Figueiras A, Barros-Dios JM. 2004. Type of wine and risk of lung cancer: a case-control study in Spain. Thorax 59:9815.
  • Ruiz MJ, Fernandez M, Pico Y, Manes J, Asensi M, Carda C, Asensio G, Estrela JM. 2009. Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem 57:31806.
  • Sacanella E, Vazquez-Agell M, Mena MP, Antunez E, Fernandez-Sola J, Nicolas JM, Lamuela-Raventos RM, Ros E, Estruch R. 2007. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. Am J Clin Nutr 86:14639.
  • Sacchi KL, Bisson LF, Adams DO. 2005. A review of the effect of winemaking techniques on phenolic extraction in red wines. Am J Enol Viticult 56:197206.
  • Saliba AJ, Bullock J, Hardie WJ. 2009. Consumer rejection threshold for 1,8-cineole (eucalyptol) in Australian red wine. Food Qual Prefer 20:5004.
  • Saliba AJ, Moran CC. 2010. The influence of perceived healthiness on wine consumption patterns. Forthcoming.
  • Sanchez-Iglesias M, Gonzalez-Sanjose ML, Perez-Magarino S, Ortega-Heras M, Gonzalez-Huerta C. 2009. Effect of micro-oxygenation and wood type on the phenolic composition and color of an aged red wine. J Agric Food Chem 57:11498509.
  • Scalbert A, Manach C, Morand C, Remesy C, Jimenez L. 2005. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287306.
  • Schroder H, Masabeu A, Marti MJ, Cols M, Lisbona JM, Romagosa C, Carion T, Vilert E, Marrugat J. 2007. Myocardial infarction and alcohol consumption: a population-based case-control study. Nutr Metab Cardiovasc Dis 17:60915.
  • Sengottuvelan M, Deeptha K, Nalini N. 2009. Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazine-induced colon carcinogenesis. Nutrition 25:116976.
  • Smith R. 2004. “Let food be thy medicine…. BMJ 328:7433.
  • Smith-Warner SA, Spiegelman D, Yaun SS, Van Den Brandt PA, Folsom AR, Goldbohm RA, Graham S, Holmberg L, Howe GR, Marshall JR, Miller AB, Potter JD, Speizer FE, Willett WC, Wolk A, Hunter DJ. 1998. Alcohol and breast cancer in women: a pooled analysis of cohort studies. J Am Med Assoc 279:53540.
  • Soleas GJ, Tomlinson G, Diamandis EP, Goldberg DM. 1997. Relative contributions of polyphenolic constituents to the antioxidant status of wines: development of a predictive model. J Agric Food Chem 45:39954003.
  • Spayd SE, Tarara JM, Mee DL, Ferguson JC. 2002. Separation of sunlight and temperature effects on the composition of Vitis vinifera cv. Merlot berries. Am J Enol Viticult 53:17182.
  • Stadtman ER. 2004. Role of oxidant species in aging. Curr Med Chem 11:110512.
  • Stockley CS, Hoj PB. 2005. Better wine for better health: fact or fiction Aust J Grape Wine Res 11:12738.
  • Subirade M. 2007. Report on functional foods. Rome : Food and Agriculture Organization of the United Nations (FAO).
  • Sun WM, Wang W, Kim J, Keng P, Yang SM, Zhang HS, Liu CM, Okunieff P, Zhang LR. 2008. Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv Exp Med Biol 614:17986.
  • Szkudelski T. 2008. The insulin-suppressive effect of resveratrol: an in vitro and in vivo phenomenon. Life Sci 82:4305.
  • Tabassum H, Parvez S, Rehman H, Banerjee BD, Raisuddin S. 2007. Catechin as an antioxidant in liver mitochondrial toxicity: inhibition of tamoxifen-induced protein oxidation and lipid peroxidation. J Biochem Mol Toxicol 21:1107.
  • Tao J, Dykes SI, Kilmartin PA. 2007. Effect of SO2 concentration on polyphenol development during red wine micro-oxygenation. J Agric Food Chem 55:61049.
  • Terra X, Montagut G, Bustos M, Llopiz N, Ardevol A, Blade C, Fernandez-Larrea J, Pujadas G, Salvado J, Arola L, Blay M. 2009. Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. J Nutr Biochem 20:2108.
  • The American Association for the Study of Liver Diseases. 2005. Liver fast facts: alcohol and the liver. Available from: http://www.aasld.org/patients/Pages/LiverFastFactsAlcoholandtheLiver.aspx . Accessed Mar 6, 2010.
  • Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW, Doll R. 1997. Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med 337:170514.
  • Tucker G, Robards K. 2008. Bioactivity and structure of biophenols as mediators of chronic diseases. Crit Rev Food Sci Nutr 48:92966.
  • US Dept. of Health and Human Services. 2005. Dietary guidelines for Americans 2005. Available from: http://www.health.gov/dietaryguidelines/dga2005/document/html/chapter9.htm . Accessed Jun 3, 2010.
  • Valdez LB, Alvarez S, Zaobornyj T, Boveris A. 2004. Polyphenols and red wine as antioxidants against peroxynitrite and other oxidants. Biol Res 37:27986.
  • Vanzo A, Terdoslavich M, Brandoni A, Torres AM, Vrhovsek U, Passamonti S. 2008. Uptake of grape anthocyanins into the rat kidney and the involvement of bilitranslocase. Mol Nutr Food Res 52:110616.
  • Vaz-Da-Silva M, Loureiro AI, Falcao A, Nunes T, Rocha JF, Fernandes-Lopes C, Soares E, Wright L, Almeida L, Soares-Da-Silva P. 2008. Effect of food on the pharmacokinetic profile of trans-resveratrol. Int J Clin Pharmacol Ther 46:56470.
  • Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P. 2008. Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neurosci 9(Suppl 2):S6. DOI: 10.1186/1471-2202-9-S2-S6.
  • Vinson JA, Teufel K, Wu N. 2001. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 156:6772.
  • Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R. 2005. Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res 49:495504.
  • Walle T, Hsieh F, Delegge MH, Oatis JE, Walle UK. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:137782.
  • Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, Pasinetti GM. 2006. Moderate consumption of Cabernet Sauvignon attenuates a beta neuropathology in a mouse model of Alzheimer's disease. FASEB J 20:231320.
  • Wang YJ, Thomas P, Zhong JH, Bi FF, Kosaraju S, Pollard A, Fenech M, Zhou XF. 2009. Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse. Neurotoxicity Res 15:314.
  • Waterhouse AL. 2002. Wine phenolics. Ann N Y Acad Sci 957:2136.
  • Weststrate JA, Van Poppel G, Verschuren PM. 2002. Functional foods, trends and future. Br J Nutr 88:S2335.
  • Whitsett TG, Lamortiniere CA. 2006. Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat. Expert Rev Anticancer Ther 6:1699706.
  • WHO. 2003. Diet, nutrition and the prevention of chronic diseases: WHO Technical Report Series 916. Available from: http://whqlibdoc.who.int/trs/WHO_trs_916.pdf . Accessed Mar 6, 2010.
  • Wiegand H, Boesch-Saadatmandi C, Regos I, Treutter D, Wolffram S, Rimbach G. 2009. Effects of quercetin and catechin on hepatic glutathione-s transferase (gst), nad(p)h quinone oxidoreductase 1 (nqo1), and antioxidant enzyme activity levels in rats. Nutr Cancer 61:71722.
  • Williams LD, Burdock GA, Edwards JA, Beck M, Bausch J. 2009. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem Toxicol 47:217082.
  • Woodall CE, Li Y, Liu QH, Wo J, Martin RCG. 2009. Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation. Anti-Cancer Drugs 20:43743.
  • [WCRF/AICR] World Cancer Research Fund/American Insti. for Cancer Research. 2007. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington , D.C. : AICR.
  • Wren AF, Cleary M, Frantz C, Melton S, Norris L. 2002. 90-day oral toxicity study of a grape seed extract (IH636) in rats. J Agric Food Chem 50:218092.
  • Yamakoshi J, Saito M, Kataoka S, Kikuchi M. 2002. Safety evaluation of proanthocyanidin-rich extract from grape seeds. Food Chem Toxicol 40:599607.
  • Young A. 2003. Making sense of wine tasting. San Francisco : Intl. Wine Acad.
  • Yu J, Smith G, Gross HB, Hansen RJ, Levenberg J, Walzem RL. 2006. Enzymatic O-methylation of flavanols changes lag time, propagation rate, and total oxidation during in vitro model triacylglycerol-rich lipoprotein oxidation. J Agric Food Chem 54:84038.
  • Zamora-Ros R, Urpi-Sarda M, Lamuela-Raventos RM, Estruch R, Martinez-Gonzalez MA, Bullo M, Aros F, Cherubini A, Andres-Lacueva C. 2009. Resveratrol metabolites in urine as a biomarker of wine intake in free-living subjects: the predimed study. Free Radic Biol Med 46:15626.
  • Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. 2005. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-ohda model of Parkinson's disease. Free Radic Res 39:111925.
  • Zern TL, Wood RJ, Greene C, West KL, Liu YZ, Aggarwal D, Shachter NS, Fernandez ML. 2005. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 135:19117.
  • Zhang JL, Stanley RA, Adaim A, Meton LD, Skinner MA. 2006. Free radical scavenging and cytoprotective activities of phenolic antioxidants. Mol Nutr Food Res 50:9961005.
  • Zhang SZ, Yang XN, Coburn RA, Morris ME. 2005. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein. Biochem Pharmacol 70:62739.
  • Zilkens RR, Burke V, Hodgson JM, Barden A, Beilin LJ, Puddey IB. 2005. Red wine and beer elevate blood pressure in normotensive men. Hypertension 45:8749.
  • Zimman A, Joslin WS, Lyon ML, Meier J, Waterhouse AL. 2002. Maceration variables affecting phenolic composition in commercial-scale Cabernet Sauvignon winemaking trials. Am J Enol Viticult 53:938.